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Abstract
Background
Studies have shown that hepatitis C virus (HCV) infection increased during the past de-
cades in China. However, little evidence is available on when, where, and who were in-
fected with HCV. There are gaps in knowledge on the epidemiological burden and evolution
of the HCV epidemic in China.
Methods
Data on HCV cases were collected by the disease surveillance system from 2005 to 2012
to explore the epidemic in Henan province. Spatiotemporal scan statistics and age-period-
cohort (APC) model were used to examine the effects of age, period, birth cohort, and
spatiotemporal clustering.
Results
177,171 HCV cases were reported in Henan province between 2005 and 2012. APCmodel-
ling showed that the HCV reported rates significantly increased in people aged > 50 years.
A moderate increase in HCV reported rates was observed for females aged about 25 years.
HCV reported rates increased over the study period. Infection rates were greatest among
people born between 1960 and 1980. People born around 1970 had the highest relative risk
of HCV infection. Women born between 1960 and 1980 had a five-fold increase in HCV in-
fection rates compared to men, for the same birth cohort. Spatiotemporal mapping showed
major clustering of cases in northern Henan, which probably evolved much earlier than
other areas in the province.
PLOS ONE | DOI:10.1371/journal.pone.0129746 June 15, 2015 1 / 14
a11111
OPEN ACCESS
Citation: Chen F, Sun D, Guo Y, Guo W, Ding Z, Li P,
et al. (2015) Spatiotemporal Scan and Age-Period-
Cohort Analysis of Hepatitis C Virus in Henan, China:
2005–2012. PLoS ONE 10(6): e0129746.
doi:10.1371/journal.pone.0129746
Academic Editor: Ravi Jhaveri, University of North
Carolina School of Medicine, UNITED STATES
Received: October 22, 2014
Accepted: May 12, 2015
Published: June 15, 2015
Copyright: © 2015 Chen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Data cannot be made
publicly available due to ethical restrictions. All
requests to access data may be submitted through
the Data-Center of China Public Health Science
(http://www.phsciencedata.cn/Share/en/data.jsp?id=
9906073c-200a-4b44-8ffe-0867bfa42557) or by email
to data@chinacdc.cn.
Funding: The authors received no specific funding
for this work.
Competing Interests: The authors have declared
that no competing interests exist.
Conclusions
Spatiotemporal mapping and APCmethods are useful to help delineate the evolution of the
HCV epidemic. Birth cohort should be part of the criteria screening programmes for HCV in
order to identify those at highest risk of infection and unaware of their status. As Henan is
unique in the transmission route for HCV, these methods should be used in other high bur-
den provinces to help identify subpopulations at risk.
Introduction
Chronic infection with hepatitis C virus (HCV) is known as the major agent of chronic liver
disease, hepatic cirrhosis, and hepatocellular carcinoma. WHO estimated that there are more
than 185 million people with chronic liver disease due to HCV infection, and over 350,000 peo-
ple die from HCV-related diseases worldwide each year [1,2]. HCV is a serious public health
problem in many developing and developed countries because of the absence of a prevention
vaccine, continued transmission through injecting drug use, unsafe blood and blood products
and unsafe medical and non-medical equipment; and lack of curative treatment regimens.
China was a relatively high endemic area of HCV infection in the past [3]. A national survey
carried out in 1992 showed that the HCV prevalence was 3.20% in general population in Main-
land China, estimated at approximately 40 million HCV infections [4]. According to another
multicenter epidemiological study between 1991 and 1995, the average HCV prevalence in gen-
eral population was over 2.2% [5]. Due to the lack of regulatory and implementation oversight
on the safety of blood and blood products, transfusion-transmitted infections (TTIs) including
HCV rapidly spread among commercial plasma donors in the 1990’s in central China, effec-
tively establishing the HCV epidemic in the country [6].
Strengthened regulations on blood safety such as mandatory screening of all donated blood
for TTIs in 1993 and implementation of voluntary blood donation policies in 1998 reduced the
risk of HCV transmitted through blood and blood products [7]. According to a meta-analysis,
the pooled prevalence of HCV infection was 12.87% (95% confidence interval, CI: 11.25%–
14.56%) among blood donors before 1998, decreased to 1.71% (95% CI: 1.43%– 1.99%) after
1998 [8].
Several provinces continue to have relatively high HCV prevalence. Since 2003, multiple
studies reported increasing HCV cases during the past decades suggesting that the risk of HCV
transmission exist [9–13]. There are gaps in knowledge on the epidemiological burden and
evolution of the HCV epidemic in China. In this study, we use HCV case-reporting data to ex-




HCV is one of the notifiable infectious diseases according to the Law of Infectious Diseases of
China amendment of 2004. A standardized case reporting form (CRF) is used for collection of
demographic and diagnostic information, including date of birth, gender, residence, occupa-
tion, date of diagnosis etc. All CRFs for newly diagnosed HCV are reported to the China Infor-
mation System for Disease Control and Prevention (CISDCP) by local physicians and health
workers since 2003. CISDCP is a web-based real-time database, which collates case reporting
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information at the national level by the National Centers of Disease Control (NCDC). All re-
ported HCV cases must be confirmed serologically as antibody-positive for HCV.
Henan is a province in central China and shoulders a large burden of HCV infection, re-
porting 14.55% (9641/66283) of all reported HCV cases in the country in 2005 and 19.78%
(39887/201622) in 2012. The province covers an area about 167 000 km2 and 170 counties, and
has approximately 94 million population.
Data of all HCV cases reported in this province during January 1st, 2005 to December 31st,
2012 was extracted from the CISDCP database.
Data analysis
To measure the intensity of HCV infection in a defined area, we used the index termed as ‘re-
ported rate’; defined as the number of reported cases and resident population as the numerator
and denominator, respectively. This index has been used in other articles on HCV case report-
ing [14,15]. Relative risks (RRs) between particular groups rather than the absolute differences
of reported rates were used to depict the spatiotemporal trends of HCV infection.
In order to observe the spatial and temporal characteristics, counts of HCV cases were cal-
culated for each district/county level by calendar year, age, gender, and birth cohort. The dis-
trict/county of HCV cases were labeled by geocode (latitude and longitude). HCV cases were
grouped into eighteen 5-year age groups, from 0 to 85+ years. Demographical data and elec-
tronic map were obtained from the information system of the NCDC.
Age-period-cohort analysis
In order to examine the trend of HCV incidence over time, three factors (age of HCV cases
when diagnose, calendar year for HCV diagnosis, and birth year of diagnosed HCV cases) were
modelled using Age-Period-Cohort (APC) model [16]. APC model separates the birth cohort
and age effect from the calendar time effect [17–19] and has been widely used to assess the
trends in disease surveillance [20] such as cancer, diabetes and mortality [21–23].
We used a Poisson regression model to fit the age-period-cohort model. A penalized spline
was used for age, and birth cohort. Period and gender were modeled as categorical variables.
The model was determined as:
logðmijÞ ¼ aþ Sðagei; df Þ þ bperiodj þ Sðcohortk; df Þ þ dgenderl þ offsetðlogðnijlÞÞ:
Where S was penalized spline, df was degree of freedom. S(agei, df) (i = 1, . . ., I) was the age ef-
fect, βperiodj was the period effect (j = 1,. . .J), S(cohortk, df) was the cohort effect (k = 1,. . .,K),
δgenderl was used to control for gender effect, and log(nij) was the offset term for population.
We compared seven partial models including null model, age only, period only, cohort only,
age + gender, period + gender, cohort + gender. The Akaike information criterion (AIC) was
used to decide the model goodness-of-fit and degree of freedom for spline [24,25]. The full
model provided the best-fit model with the lowest AIC values (Table 1). The effect of age, peri-
od and cohort was expressed as estimated relative risk with two-tailed 95% confidence inter-
vals. All analyses were performed by R software, version 3.1.0 (R Development Core Team,
Vienna, Austria). The “mgcv” package was used to perform Poisson regression model.
Spatiotemporal scan analysis
The SaTScan software (Version 9.3) was used to perform spatiotemporal scan statistics [26] to
detect the temporal and spatial clustering of reported HCV cases. This method identifies the
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presence, locations and temporal window of the clusters [22] and is widely used to detect clus-
tering in a number of health-related fields [27–30].
The essential principle was to allow circular windows of different sizes to range across the
study region. Potential clusters in Henan province was explored by scanning each location (dis-
trict/county) with a flexible size of the radius of the window from 0 to the upper limit, defined
at 50% by default. The window size was determined by the percentage of the total population
size in the area. For each location and size of the scanning window, a likelihood ratio was com-
puted for the alternative hypothesis that there was an increased risk of disease inside the circle
[31]. The likelihood function was maximized over all window locations and sizes, and the cir-
cular windows with the maximum likelihood ratio values were identified as the most
likely cluster.
Outputs of this method included a cylindrical window with a circular geographic base with
height corresponding time [32]. An associated P value, based on Monte Carlo hypothesis test-
ing [33], was used to evaluate whether the cases are randomly distributed. For each simulation,
the likelihood ratio statistic was computed and the observed value compared with the set of
simulated values to find the significance probability. The number of simulations was restricted
to 999. Clusters with statistical significance of P<0.05 were reported.
Separate analyses were performed for: pure spatial clusters, spatiotemporal clusters for cal-
endar periods and spatiotemporal clusters for birth cohorts. As the onset of the disease was de-
pendent on age and gender, covariate adjustment in SaTScan was used to identify pure spatial
and spatiotemporal clusters. ArcGIS 10.0 (ESRI Inc., Redlands, CA, USA) was used to present
the results of clustering in the electronic maps.
Ethics
This study was approved by the Institutional Review Board of National Center for AIDS/STD
Control and Prevention, Chinese Center for Disease Control and Prevention (IRB: 00002276).
The analyses used data extracted from the routine CISDCP case reporting database of Henan.
Permission for data use was approved by China CDC (Email: data@chinacdc.cn for public
use). Information extracted was at population-level and did not include individual patient data
or personal identifiers.
Results
There were 177,171 HCV reported cases in Henan between 2005 and 2012. Only 0.5%
(n = 803) of cases were excluded owing to lack of geographic information. The number of
HCV reported cases increased by calendar year from 8,123 in 2005 to 39,887 in 2012. The gen-
der ratio of HCV reported cases (male/female) was close to 1, and the median age was 47 years.
Table 1. Results from the APCmodeling.
Model Variables AIC df
0 Null model 445814.8 1.00
1 Age 332515.4 9.98
2 Period 412621.4 8.00
3 Cohort 342639.5 9.96
4 Age + Gender 332478.7 10.98
5 Period + Gender 412361.8 9.00
6 Cohort + Gender 342584.9 10.96
7 Age + Period + Cohort + Gender 299215.8 25.88
doi:10.1371/journal.pone.0129746.t001
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APC study
Fig 1 shows the age effect on the reported HCV infection rates. Overall reported rates were sim-
ilar across age-groups until about 50 years of age, thereafter increasing between two to four-
fold from 60 to 80 years. Overall, both men and women had similar trends of HCV infection.
In women of 25 years of age, however, there was a small but noticeable increase in infection
rates. Reported HCV rates increased between 2005 and 2012, with a marked increase from
2010 (Fig 2).
In general, reported HCV rates were higher in birth cohorts born between 1960 and 1980,
compared to before 1960 and after 1980 (Fig 3). People born around the 1970s have the greatest
rates of infection. Women born between 1960 and 1980 had a five-fold increase in HCV infec-
tion rates compared to men, for the same birth cohort. A second smaller peak in HCV infection
was seen in women born around the year 2000.
Spatiotemporal analysis adjusting for age and gender
Purely spatial. Pure spatial clustering analysis examined five clusters during 2005–2012
(Table 2, Fig 4A). The most likely cluster was centered in 35.2571N, 113.2750E, Shanyang dis-
trict and encompassing a radius of 108.61 km, including 45 districts/counties. 70103 cases were
reported against the 37341.46 expected and the cluster had a relative risk (RR) of 2.46
(P<0.01). Four statistically significant secondary clusters were identified (Table 2).
Controlling for calendar period. Table 3 and Fig 4B showed the result from the spatio-
temporal analysis by calendar period after adjusting for age and gender. Analysis identified two
clusters of high infection rates between 2005 and 2012. The first cluster was centered within a
118.02 km radius in the north of Henan province during 2009 to 2012 (RR = 2.60, P<0.01).
The other cluster was centered in a radius of 87.75 km in southern Henan during 2010 to 2012
(RR = 2.09, P<0.01).
Controlling for birth cohort. Four clusters of elevated risk of HCV infection were found
by spatiotemporal analysis for birth cohort (Table 4 and Fig 4C). The first cluster consisted of
residents born during the period 1931–1975 in northern Henan (RR = 2.48, P<0.01). Notably,
this cluster was similarly located with a size approximated to the cluster found in spatial analy-
sis and controlled for calendar period. The second cluster was found for people born between
1950 and 1994 in the south of Henan (reported cases n = 5,779 against the expected
n = 2,237.82; RR = 2.64, P<0.01). The third cluster was found for people born during 1945–
1978 in southern Henan. Lastly, the fourth cluster was noted in a specific county in eastern
Henan among people born during 2009–2010 in Yongcheng district (RR = 21.39, P<0.01).
Discussion
Henan has the highest burden of HCV in China [34]. The number of HCV reported cases in
this province have gradually increased from 2005 to 2012. To better understand the evolution
of the epidemic, we depict the temporal and spatial characteristics of HCV infection from case-
reporting data collected during 2005–2012.
HCV case reporting increased gradually per calendar year. This was likely due to scale-up of
testing and reporting practices. A slight increase in rates of reporting from 2010 was found and
can be attributed to strengthening and special management of HCV surveillance. Since 2009,
HCV surveillance was gradually integrated into national HIV/STD surveillance by enhancing
case reporting management, adding anti-HCV testing to HIV sentinel surveillance and estab-
lishing HCV specific sentinel surveillance sites [35]. In Henan this work has been transferred
from the Institute of Immunization Program to the Institute of Prevention and Control of
Spatiotemporal Analysis for Hepatitis C Virus
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Fig 1. Age effect from the full APCmodel for all (A), male (B) and female (C). The continuous
line = estimated effect of age; dashed lines = 95% confidence interval of the estimates.
doi:10.1371/journal.pone.0129746.g001
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Fig 2. Period effect from the full APCmodel for all (A), male (B) and female (C). The continuous
line = estimated effect of period; dashed lines = 95% confidence interval of the estimates.
doi:10.1371/journal.pone.0129746.g002
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Fig 3. Cohort effect from the full APCmodel for all (A), male (B) and female (C). The continuous
line = estimated effect of cohort; dashed lines = 95% confidence interval of the estimates.
doi:10.1371/journal.pone.0129746.g003
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STD/AIDS since 2010, which is responsible for staff training, surveillance and case manage-
ment, amongst others.
We noted that the HCV infection rates increased with age, especially in older people more
than 50 years. This result was similar to previous provincial and national cross-sectional stud-
ies in Henan and China [36,37]. This could be a cumulative effect of exposure to HCV trans-
mission risks over a lifetime. Late diagnosis of HCV infection is common because of low
awareness and knowledge of HCV such as that found in a national survey [38] and the slow
and asymptomatic clinical course of most HCV infections [39]. Our analysis has also detected
an apparent birth cohort effect with people born between 1960 and 1980 having the highest
risk of infection. This birth cohort may have had specific exposure to HCV. In 1995, commer-
cial plasma donation became popular in poor rural communities in Henan [40] and a previous
history of this constitutes a major risk for TTI infection. People born in 1960 to 1980 were in
their young adulthood or working during this time and may have been exposed to HCV
through this route.
Interestingly, we noted gender differences of HCV infection risk. Women born between
1960 and 1980 had a five-fold increase in risk compared to men. In men, this risk of HCV in-
fection was only slightly higher for those born between 1960 and 1980, compared to those born
before or after these years, respectively. These variations among men and women suggest dif-
ferences in risks and risk behavior. In the traditional culture of central China, men and women
had different roles in family and society. Men were considered responsible for their family and
were usually the main breadwinner. Driven by economic necessity, commercial plasma dona-
tion could have been a financial source. Women after their reproductive age or having finished
their main childcare responsibilities may be driven by these same interests. Younger women
may have been exposed to HCV infection through unsafe blood or blood products during preg-
nancy, labour and delivery; or unsafe medical practices during this time.
Spatiotemporal analysis results showed a large cluster of HCV cased in northern Henan for
which the birth period was 1931–1975. Secondary clusters were located around Zhumadian in
southern Henan, where most cases were born in 1950–1994. The lack of overlap in the birth co-
horts suggests that the HCV epidemic in the north evolved much earlier than in the south.
Northern Henan has a long history of a strong and developed economy with established
medical facilities compared to other cities in the province, and is the major hub for in-
migration from other areas [41]. Higher and earlier reporting of HCV may be due to better ac-
cess of health care, testing and better clinical capacities for diagnosis. High demand of blood
may have fueled commercial plasma donation earlier in this area.
In southern Henan, HCV infection occurred in a mainly rural population with an undeveloped
economy, mostly from former plasma donation [42]. A survey of one village with more paid plas-
ma donors in this region found that, HCV prevalence in paid plasma donors and other villagers
were 73.76% and 8.04%, higher than that of general population in China (3.20%), and their preva-
lence has also increased with the total times of paid plasma donation [43].
Table 2. Spatial analysis of hepatitis C, using the discrete Poissonmodel of purely spatial statistic.
Cluster Cluster center Radius (km) No. districts/counties Population No. of cases Expected cases LLR RR P value
1 Shanyang dis 108.61 km 45 19014344 70103 37341.46 15598.70 2.46 <0.01
2 Yicheng dis 27.87 km 3 1505871 7045 3071.02 1921.47 2.35 <0.01
3 Wancheng dis 0 km 1 790250 3708 1637.46 972.50 2.29 <0.01
4 Shihe dis 34.60 km 2 1272970 3808 2548.23 274.50 1.51 <0.01
5 Shangcai 0km 1 1195144 3203 2190.43 207.49 1.47 <0.01
doi:10.1371/journal.pone.0129746.t002
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Fig 4. Results from the spatiotemporal scan analysis. (A) Five clusters identified for purely spatial. (B)
Two clusters identified for calendar periods and place of living. (C) Four clusters identified for birth cohorts
and place of living.
doi:10.1371/journal.pone.0129746.g004
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Lastly, a specific county confined to Yongcheng in 2009–2010 was found in the secondary
clusters by birth year and space analysis. People born during this specific interval period and
living in this region had very high infection risk. During this period, an outbreak of HCV infec-
tion occurred in Guoyang county of Anhui province and Yongcheng city of Henan province in
late November, 2011 [44]. This local event was related to use of intravenous infusion and un-
safe medical injection, two of which were the most common treatments in primary care in
China [45]. WHO reported that unsafe injection is the most common cause of HCV injection
in developing and transitional countries, causing two million new infections each year and ac-
counting for 42% of cases [46]. A study of 1000 HCV cases registered in a hospital found that
8% of HCV infection were acquired from previous nosocomial infection such as hemodialysis,
operation, injection, intravenous infusions for therapy and dental treatment [47]. Similarly,
nosocomial infection of hepatitis C has been reported in other countries such as Egypt [48],
France [49], Vietnam [50], Canada [51].
In summary, the age-period-cohort model and spatiotemporal scan methods applied to case
reporting data and is useful in understanding the epidemiology and evolution of HCV epidem-
ic. Our study confirmed differences of HCV risk for birth cohorts, men and women and clus-
tering of cases in northern and southern Henan. In order to improve screening and detect
those at highest risk, birth cohort should added as a criteria for testing in the national pro-
gramme. It is critical that blood safety be strengthened as well as safe medical injection prac-
tices in health settings.
Strengths and limitations
To the best of our knowledge, this is the first study which uses spatiotemporal scan and the
APC model to analyze HCV case reporting data. These methods help to elucidate the distribu-
tion and trends of HCV infection in spatial and temporal dimensions. The analysis of HCV in-
fection over time and across geographic regions has an important role in disease surveillance
and implications for programme approaches.
We used ‘reported rate’ as the measurement of disease occurrence and especially focus on
trends of relative risks (RRs) of HCV infection between groups. We took into account the back-
ground population in detecting spatiotemporal distribution of HCV and standardize HCV re-
ported cases to the underlying population at risk, which was helpful to better understand















1 2009–2012 Wushe 118.02 km 58 26880878 56694 27142.00 15349.08 2.60 <0.01
2 2010–2012 Tongbai 87.75 km 10 6610835 10355 5111.26 2148.25 2.09 <0.01
doi:10.1371/journal.pone.0129746.t003















1 1931–1975 Xiuwu 88.31 km 31 1125921 43125 20369.12 11338.32 2.48 <0.01
2 1950–1994 Yicheng dis. 27.87 km 3 132377 5779 2237.82 1977.77 2.64 <0.01
3 1945–1978 Wancheng
dis.
0 km 1 69473 2981 1150.56 1017.10 2.62 <0.01
4 2009–2010 Yongcheng 0 km 1 113015 195 9.13 411.28 21.39 <0.01
doi:10.1371/journal.pone.0129746.t004
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potential factors influencing the occurrence in this region. Determining the true incidence of
HCV infection (i.e., the rate of newly acquired infections) was difficult because most acute in-
fections are asymptomatic, and available diagnostic assays do not distinguish acute from
chronic or resolved infection [3].
The data used in this study relies on routine disease surveillance which has its limitations.
Case reporting is influenced by program and health system factors including the extent of pre-
vention efforts and access to diagnostic facilities. There are known issues with case reporting
data such as reporting biases, duplicate and underreporting. Duplicate reporting of HCV re-
ported cases in Henan in a previous survey was shown to be about 4–5% each year [52]. More-
over, data was extracted only for eight years from 2005–2012 which may be relatively limited
in order to show more marked temporal trends.
We are unable to use this analysis to draw a clear etiology conclusion using case reporting
data. However, the approach used was useful to explore possible reasons for HCV cases as is re-
ported in a geographical region since there is inadequate information on the epidemic. Under-
standing possible routes or transmission factors help to optimize prevention and control
efforts, and better target geographical areas with higher burden of HCV.
Additional research questions
As the route of transmission in Henan is unique to the central provinces of China, further stud-
ies should be conducted to understand the epidemiology and evolution of HCV in other prov-
inces with substantial burden of infection.
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